Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,495 across all filing types
Latest filing 2014-04-01 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2014
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/03/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related movements. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement of a report. The document length is over 13,000 characters, indicating substantive content rather than a brief announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a regulatory compliance document reporting share capital movements to the exchange.
2014-04-01 English
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of Hongkong Chinese Limited regarding the change of address of the Hong Kong Branch share registrar and transfer office. It is a short announcement (1675 characters) and does not contain any financial data, report content, or detailed analysis. It is not a report itself but an operational update related to company administration. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-03-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2014
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28/02/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement. The document is lengthy (over 12,000 characters) and contains detailed data, not just an announcement or certification. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other specific categories like capital changes (SHA) or director dealings (DIRS). It is not a capital/financing update (CAP) because it does not discuss fundraising or financing activities but only share capital movements. It is not a share issue/capital change (SHA) because SHA typically covers announcements of new share issues or stock splits, whereas this is a monthly return report of movements in securities submitted to the exchange. Hence, the most appropriate classification is Regulatory Filings (RNS).
2014-03-03 English
JOINT ANNOUNCEMENT - SHARE OF RESULTS OF, AND DISTRIBUTION IN SPECIE BY, A LISTED SUBSIDIARY OF A PRINCIPAL JOINT VENTURE
Regulatory Filings Classification · 95% confidence The document is a joint announcement by Lippo Limited and Hongkong Chinese Limited pursuant to Rule 13.09 of the Listing Rules and Inside Information Provisions. It discusses the unaudited full year financial results of a listed subsidiary (OUE Limited) for the year ended 31 December 2013, and details about a proposed distribution in specie by OUE. The announcement references previous announcements and provides information on shareholding and expected financial impacts. It does not contain full financial statements or detailed financial analysis itself but serves as a regulatory announcement about inside information and shareholding changes related to a joint venture. The document length is 6272 characters, which is moderate but the content is clearly an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and inside information disclosure under listing rules, not as a full Annual Report, Interim Report, or Earnings Release.
2014-02-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2014
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/01/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a Major Shareholding Notification or Share Issue/Capital Change report. However, since it covers detailed monthly movements in securities and share capital, it aligns best with the Share Issue/Capital Change (SHA) category, which includes announcements regarding new share issues, stock splits, or other capital changes. The document is substantive and not merely an announcement of a report, so it is not RPA or RNS. Therefore, the classification is SHA with high confidence.
2014-02-04 English
JOINT ANNOUNCEMENT - COMPLETION OF THE PROPOSED DISPOSAL BY A LISTED SUBSIDIARY OF A PRINCIPAL JOINT VENTURE
Regulatory Filings Classification · 95% confidence The document is a joint announcement by Lippo Limited and Hongkong Chinese Limited regarding the completion of a proposed disposal by a listed subsidiary of a principal joint venture. It references compliance with Rule 13.09 of the Listing Rules and Inside Information Provisions, indicating it is a regulatory announcement. The content focuses on the completion of a transaction involving disposal of interest and issuance of units in a REIT, with details on consideration and shareholding percentages. There are no financial statements or detailed financial performance data included, nor is this a report or presentation. The document is an official announcement of a corporate transaction event, not a full report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2014-01-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.